Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Iuliia, Weber"'
Publikováno v:
Stem Cells International, Vol 2015 (2015)
Mesenchymal stem/stromal cells (MSCs) represent a promising cell source for research and therapeutic applications, but their restricted ex vivo propagation capabilities limit putative applications. Substantial self-renewing of stem cells can be achie
Externí odkaz:
https://doaj.org/article/d8a6dfd0f0624127972ec20a15db9ad1
Autor:
Norman Huang, Iuliia Weber, Hans-Ulrich Pfeiffer, Erhard Seifried, Reinhard Henschler, Michael Schmidt, Anna Erickson, Johannes Leibacher, Laurence Corash, Christine Ernst, Richard J. Benjamin, Katharina Madlener, Sarah Dombos, Markus Müller, Nina Mufti, Veronika Brixner, AH Kiessling, Anne North, Salvador Rico, Christof Geisen
Publikováno v:
Transfusion. 58:905-916
Background Nucleic acid-targeted pathogen inactivation technology using amustaline (S-303) and glutathione (GSH) was developed to reduce the risk of transfusion-transmitted infectious disease and transfusion-associated graft-versus-host disease with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::eb04c97d740d6ef4faed53a290fc9e71
https://doi.org/10.1111/trf.14528
https://doi.org/10.1111/trf.14528
Autor:
Veronika, Brixner, Arndt-Holger, Kiessling, Katharina, Madlener, Markus M, Müller, Johannes, Leibacher, Sarah, Dombos, Iuliia, Weber, Hans-Ulrich, Pfeiffer, Christof, Geisen, Michael, Schmidt, Reinhard, Henschler, Anne, North, Norman, Huang, Nina, Mufti, Anna, Erickson, Christine, Ernst, Salvador, Rico, Richard J, Benjamin, Laurence M, Corash, Erhard, Seifried
Publikováno v:
Transfusion. 58(4)
Nucleic acid-targeted pathogen inactivation technology using amustaline (S-303) and glutathione (GSH) was developed to reduce the risk of transfusion-transmitted infectious disease and transfusion-associated graft-versus-host disease with red blood c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::485e0e2bbac5d9a34510dd37116dd01d
https://pubmed.ncbi.nlm.nih.gov/29498049
https://pubmed.ncbi.nlm.nih.gov/29498049
Autor:
Matthias Theobald, Andreas Mades, Shamsul A. Khan, Udo F. Hartwig, Iuliia Weber, Janina Petry
Publikováno v:
Blood. 124:1112-1112
Introduction: Adoptive cellular therapy (ACT) of donor-derived cytolytic T lymphocytes (CTL) directed to leukemia or herpesvirus has proven promising to improve antiviral and antileukemic immunity in patients following allogeneic hematopoietic stem c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0c412db9cc2968bfbf008954cc40c255
https://doi.org/10.1182/blood.v124.21.1112.1112
https://doi.org/10.1182/blood.v124.21.1112.1112